JSM Biotechnology and Biomedical Engineering

Recent Antimicrobial Developments Targeting Peptidyl-tRNA Hydrolases

Editorial | Open Access

  • 1. Department of Chemistry, University of Alabama in Huntsville, USA
+ Show More - Show Less
Corresponding Authors
Robert L. McFeeters, Department of Chemistry, University of Alabama in Huntsville, 301 Sparkman Drive, Huntsville, AL, 35899, USA

Peptidyl-tRNA hydrolases (Pths) are essential enzymes found in bacteria, archaea, and eukaryotes. Pths cleave the peptide:tRNA ester bond of peptidyl-tRNAs generated from premature termination of protein synthesis and the expression of short ORFs or minigenes. Accumulation of peptidyl-tRNAs is toxic presumably due to impaired translational initiation or slowed protein synthesis caused by specific tRNA starvation. Pth activity is thus vital for cells to deal with the build-up of peptidyl-tRNAs.

Bacterial genomes encode a highly conserved peptidyl-tRNA hydrolase enzyme, Pth1. Amino acid sequence homology is high across all species and active site residues are strictly conserved. Structures of Pth1 have been solved for several species and catalytically important residues identified. Studies with mini- and partial-substrates have contributed to understanding of substrate recognition. However, the mechanism of action and ability to distinguish between aminoacyl- and peptidyl-tRNAs are not fully understood.

Better understanding of this fundamental biological enzyme has contributed to pharmacological development against this promising new antibacterial target. Expediting the time consuming northern blot assay has paved the way for moderate screening efforts and identification of inhibitory natural product extracts. Computational small molecule docking has also provided initial insight. Overall, Pth1 is a promising new antibacterial target and continued characterization will advance antibiotic development.


McFeeters RL (2013) Recent Antimicrobial Developments Targeting Peptidyl-tRNA Hydrolases. JSM Biotechnol Bioeng 1(1): 1006.


•    Peptidyl-tRNA hydrolase
•    Antibiotic
•    Antibacterial


Pth Activity is essential and Ubiquitous

Peptidyl-tRNAs are generated when ribosomes abort translation prematurely [1-3], which occurs on average 10% of the time [4]. Peptidyl-tRNAs are then released by ribosome recycling factor and elongation factor-G [4,5], are rescued (i.e. by tmRNA [6] or YaeJ [7,8]), or fall-off at a rate depending on the attached tRNA [9]. Build-up of peptidyl-tRNAs results in tRNA starvation and rapid cell death. Accumulation of peptidyl-tRNAs also results from the expression of minigenes or short ORFs [10- 12]. To avoid excessive build-up of polluting peptidyl-tRNA, it is vital for cells to maintain peptidyl-tRNA hydrolase activity.

Pth activity is universal throughout all kingdoms of life. However, unlike the highly conserved Pth enzymes in bacteria, referred to as Pth1 enzymes, multiple Pths (Pth1, Pth2, and Pth-like domains) are found in archaea and eukaryotes. There is no sequence or structural homology between Pth1 and Pth2 enzymes and the mechanism of bacterial Pth1 action has been demonstrated to be completely different from that of Pth2 [13]. In rabbit reticulocytes, peptidyl-AMP and tRNA-CC are the products of the reaction [14] not just tRNA and peptide. Also, the ability to cleave bacterial initiator fmet-tRNAMet was found in reticulocytes, a property absent in bacterial Pth1s [15,16].

Structures of Pth1 and Pth2 enzymes have been solved. Focusing on Pth1, the crystal structure of the 21 kDa E. coli Pth1 monomer was solved to 1.2 Å [17]. More recently, crystal and solution structures for M. tuberculosis Pth1 have been reported [18,19] along with Pth1 from other pathogenic species including P. aeruginosa [20], F. tularensis [21], M. smegmatis [22], and A. baumannii [23]. As predicted from the high degree of amino acid sequence similarity, all have the same backbone fold. Pth1 family members are globular, single domain proteins that have a central mixed β-sheet surrounded by α-helices (Figure 1). Helix-4 occludes three residues, N10, H20, and D93 (as numbered in E. coli Pth1), identified by site directed mutagenesis to be crucially involved in enzyme activity [24]. 15N NMR relaxation data suggest the putative active site and the helix-4 cover exhibit motions on the millisecond to microsecond timescale, thought to be linked to interaction with the peptidyl-tRNA substrate [18]. 

Speculation on the enzymatic mechanism include H20 acting as a catalytic base. Residues K105 and R133 are suggested to be involved in clamping the 5’-phosphate group of the tRNA moiety [17,24-26]. Structural information is needed to resolve these postulates, yet no structure of the enzyme-substrate complex has been determined for any Pth.

Pth1 is a Promising Target for Antibacterial Development

With the relentless development of drug resistance and re-emergence of many pathogenic bacteria, the need for new antibiotics and new antibiotic targets is urgent and growing [27,28]. It is well known that the number of antimicrobial agents being brought to market has steadily declined [29]. Pth1 provides a much needed avenue for novel antibacterial development. The essential function, high conservation across bacterial species, and lack of essential human equivalent make Pth1 a prime target for antibacterial development. The high amino acid sequence conservation across bacterial species suggests a small molecule inhibitor found against one is likely to work against many others. Thus, broad spectrum inhibitors targeting Pth1 are a distinct possibility.

Targeting a new essential bacterial enzyme, Pth1 inhibitors will be effective against drug resistant strains and provide the potential for fresh, new, and original combinatorial therapies. Although bacteria have but a single class of Pth enzyme, eukaryotes possess several structurally unrelated Pth enzymes that subsume peptidyl-tRNA hydrolase activity. Pth1 knock out does not alter cell viability in yeast [30], thus Pth1 does not appear to be essential in eukaryotes. The very different structure for Pth2 [13,31-33] and Pth-domain containing proteins [34,35] mitigates concern for mitochondrial Pth impairment.

Molecular modeling studies indicate two proximal binding sites for small molecules on either side of the catalytically important H20 residue, in the crevice containing the putative active site [18]. The next step in targeted inhibition is already underway. Natural product screening shows promise for revealing Pth1 specific inhibitors [36,37]. Also, screening of a custom combinatorial library has also revealed a family of compounds that show potent in vitro and in vivo inhibition. Both show that Pth1 specific inhibition is possible, not inhibiting Pth2 in vitro.


The solid structural biology foundation and first identification of specific small molecule inhibition of Pth1 are beginning to bridge the gap between in vitro biochemical studies and lead compound identification. Such translational progress will continue, aided by medicinal chemistry and computational studies further contributing to small molecule binding studies. Overall, Pth1 is a promising new antibacterial target and comprehensive characterization will significantly advance structural biology of the system, understanding of the Pth:peptidyl-tRNA interaction, and possibly development of next generation antibiotics.


1. Jørgensen F, Kurland CG. Processivity errors of gene expression in Escherichia coli. J Mol Biol. 1990; 215: 511-521.

2. Manley JL. Synthesis and degradation of termination and prematuretermination fragments of beta-galactosidase in vitro and in vivo. J Mol Biol. 1978; 125: 407-432.

3. Kurland CG, Ehrenberg M. Constraints on the accuracy of messenger RNA movement. Q Rev Biophys. 1985; 18: 423-450.

4. Heurgué-Hamard V, Karimi R, Mora L, MacDougall J, Leboeuf C, Grentzmann G, et al. Ribosome release factor RF4 and termination factor RF3 are involved in dissociation of peptidyl-tRNA from the ribosome. EMBO J. 1998; 17: 808-816.

5. Karimi R, Pavlov MY, Heurgué-Hamard V, Buckingham RH, Ehrenberg M. Initiation factors IF1 and IF2 synergistically remove peptidyl-tRNAs with short polypeptides from the P-site of translating Escherichia coli ribosomes. J Mol Biol. 1998; 281: 241-252.

6. Singh NS, Varshney U. A physiological connection between tmRNA and peptidyl-tRNA hydrolase functions in Escherichia coli. Nucleic Acids Res. 2004; 32: 6028-6037.

7. Handa Y, Inaho N, Nameki N. YaeJ is a novel ribosome-associated protein in Escherichia coli that can hydrolyze peptidyl-tRNA on stalled ribosomes. Nucleic Acids Res. 2011; 39: 1739-1748

8. Gagnon MG, Seetharaman SV, Bulkley D, Steitz TA. Structural basis for the rescue of stalled ribosomes: structure of YaeJ bound to the ribosome. Science. 2012; 335: 1370-1372.

9. Menninger JR. The accumulation as peptidyl-transfer RNA of isoaccepting transfer RNA families in Escherichia coli with temperature-sensitive peptidyl-transfer RNA hydrolase. J Biol Chem. 1978; 253: 6808-6813.

10. Cruz-Vera LR, Hernandez-Ramon E, Perez-Zamorano B, Guarneros G. The rate of peptidyl-tRNA dissociation from the ribosome during minigene expression depends on the nature of the last decoding interaction. J Biol Chem. 2003; 278: 26065-26070.

11. Hernández-Sánchez J, Valadez JG, Herrera JV, Ontiveros C, Guarneros G. lambda bar minigene-mediated inhibition of protein synthesis involves accumulation of peptidyl-tRNA and starvation for tRNA. EMBO J. 1998; 17: 3758-3765.

12. Tenson T, Herrera JV, Kloss P, Guarneros G, Mankin AS. Inhibition of translation and cell growth by minigene expression. J Bacteriol. 1999; 181: 1617-1622.

13. Fromant M, Schmitt E, Mechulam Y, Lazennec C, Plateau P, Blanquet S. Crystal structure at 1.8 A resolution and identification of active site residues of Sulfolobus solfataricus peptidyl-tRNA hydrolase. Biochemistry. 2005; 44: 4294-4301.

14. Gross M, Crow P, White J. The site of hydrolysis by rabbit reticulocyte peptidyl-tRNA hydrolase is the 3’-AMP terminus of susceptible tRNA substrates. J Biol Chem. 1992; 267: 2080-2086.

15. Schulman LH, Pelka H. The structural basis for the resistance of Escherichia coli formylmethionyl transfer ribonucleic acid to cleavage by Escherichia coli peptidyl transfer ribonucleic acid hydrolase. J Biol Chem. 1975; 250: 542-547.

16. Dutka S, Meinnel T, Lazennec C, Mechulam Y, Blanquet S. Role of the 1-72 base pair in tRNAs for the activity of Escherichia coli peptidyltRNA hydrolase. Nucleic Acids Res. 1993; 21: 4025-4030.

17. Schmitt E, Fromant M, Plateau P, Mechulam Y, Blanquet S. Crystallization and preliminary X-ray analysis of Escherichia coli peptidyl-tRNA hydrolase. Proteins. 1997; 28: 135-136.

18. Pulavarti SV, Jain A, Pathak PP, Mahmood A, Arora A. Solution structure and dynamics of peptidyl-tRNA hydrolase from Mycobacterium tuberculosis H37Rv. J Mol Biol. 2008; 378: 165-177.

19. Selvaraj M, Roy S, Singh NS, Sangeetha R, Varshney U, Vijayan M. Structural plasticity and enzyme action: crystal structures of mycobacterium tuberculosis peptidyl-tRNA hydrolase. J Mol Biol. 2007; 372: 186-193.

20. Hughes RC, McFeeters H, Coates L, McFeeters RL. Recombinant production, crystallization and X-ray crystallographic structure determination of the peptidyl-tRNA hydrolase of Pseudomonas aeruginosa. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012; 68: 1472-1476.

21. Clarke TE, Romanov V, Lam R, Gothe SA, Peddi SR, Razumova EB, et al. Structure of Francisella tularensis peptidyl-tRNA hydrolase. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011; 67: 446-449.

22. Kumar A, Singh N, Yadav R, Kumar RP, Sharma S, Arora A, et al. Crystal structure of peptidyl-tRNA hydrolase from mycobacterium smegmatis reveals novel features related to enzyme dynamics. Int J Biochem Mol Biol. 2012; 3: 58-69.

23. Kaushik S, Singh N, Yamini S, Singh A, Sinha M, Arora A, et al. The Mode of Inhibitor Binding to Peptidyl-tRNA Hydrolase: Binding Studies and Structure Determination of Unbound and Bound Peptidyl-tRNA Hydrolase from Acinetobacter baumannii. PLoS One. 2013; 8: e67547.

24. Goodall JJ, Chen GJ, Page MG. Essential role of histidine 20 in the catalytic mechanism of Escherichia coli peptidyl-tRNA hydrolase. Biochemistry. 2004; 43: 4583-4591.

25. Ostheimer GJ, Hadjivassiliou H, Kloer DP, Barkan A, Matthews BW. Structural analysis of the group II intron splicing factor CRS2 yields insights into its protein and RNA interaction surfaces. J Mol Biol. 2005; 345: 51-68.

26. Ito K, Murakami R, Mochizuki M, Qi H, Shimizu Y, Miura K, et al. Structural basis for the substrate recognition and catalysis of peptidyltRNA hydrolase. Nucleic Acids Res. 2012; 40: 10521-10531.

27. Morens DM, Folkers GK, Fauci AS. The challenge of emerging and reemerging infectious diseases. Nature. 2004; 430: 242-249. 28.Morens DM, Folkers GK, Fauci AS. Emerging infections: a perpetual challenge. Lancet Infect Dis. 2008; 8: 710-719.

29. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48: 1-12.

30. Rosas-Sandoval G, Ambrogelly A, Rinehart J, Wei D, Cruz-Vera LR, Graham DE, et al. Orthologs of a novel archaeal and of the bacterial peptidyl-tRNA hydrolase are nonessential in yeast. Proc Natl Acad Sci U S A. 2002; 99: 16707-16712.

31. De Pereda JM, Waas WF, Jan Y, Ruoslahti E, Schimmel P, Pascual J. Crystal structure of a human peptidyl-tRNA hydrolase reveals a new fold and suggests basis for a bifunctional activity. J Biol Chem. 2004; 279: 8111-8115.

32. Powers R, Mirkovic N, Goldsmith-Fischman S, Acton TB, Chiang Y, Huang YJ, et al. Solution structure of Archaeglobus fulgidis peptidyltRNA hydrolase (Pth2) provides evidence for an extensive conserved family of Pth2 enzymes in archea, bacteria, and eukaryotes. Protein Sci. 2005; 14: 2849-61.

33. Shimizu K, Kuroishi C, Sugahara M, Kunishima N. Structure of peptidyltRNA hydrolase 2 from Pyrococcus horikoshii OT3: insight into the functional role of its dimeric state. Acta Crystallogr D Biol Crystallogr. 2008; 64: 444-453.

34. Singarapu KK, Xiao R, Acton T, Rost B, Montelione GT, Szyperski T. NMR structure of the peptidyl-tRNA hydrolase domain from Pseudomonas syringae expands the structural coverage of the hydrolysis domains of class 1 peptide chain release factors. Proteins. 2008; 71: 1027-1031.

35. Handa Y, Hikawa Y, Tochio N, Kogure H, Inoue M, Koshiba S, et al. Solution structure of the catalytic domain of the mitochondrial protein ICT1 that is essential for cell vitality. J Mol Biol. 2010; 404: 260-273.

36. Harris SM, McFeeters H, Ogungbe IV, Cruz-Vera LR, Setzer WN, Jackes BR, et al. Peptidyl-tRNA hydrolase screening combined with molecular docking reveals the antibiotic potential of Syzygium johnsonii bark extract. Nat Prod Commun. 2011; 6: 1421-1424.

37. McFeeters H, Gilbert MJ, Thompson RM, Setzer WN, Cruz-Vera LR, McFeeters RL. Inhibition of essential bacterial peptidyl-tRNA hydrolase activity by tropical plant extracts. Nat Prod Commun. 2012; 7: 1107-1110.

Received : 23 Aug 2013
Accepted : 24 Aug 2013
Published : 26 Aug 2013
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X